FDA Approved: OXYTROL — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for OXYTROL (oxybutynin) from Allergan, authorizing changes to the product via a supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• OXYTROL (OXYBUTYNIN)

Snippet

SUPPL AP for OXYTROL (OXYBUTYNIN)